Not Yet Recruiting
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
NCT07365410
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China